Navigation Links
Former NBA Star Allan Houston Joins "Apply Yourself!" Campaign to Raise Awareness of Osteoarthritis Hand and Knee Pain
Date:5/9/2011

pical products, such as sunscreens, cosmetics, lotions, moisturizers, or insect repellants.

Other information about NSAIDs:

  • Aspirin, which is an NSAID, can cause bleeding in the brain, stomach, and intestines. Aspirin can also cause ulcers in the stomach and intestines

You should not use Voltaren Gel with oral NSAIDs.

The most common side effects reported in studies using Voltaren Gel were application site reactions, including dermatitis (reported in 7% of treated patients).

Use Voltaren Gel exactly as prescribed by your healthcare provider.

  • Apply Voltaren Gel to clean, dry skin that does not have any cuts, infections, or rashes
  • Avoid exposing skin where you apply Voltaren Gel to sunlight and artificial light, such as tanning booths
  • Do not get Voltaren Gel in your eyes, nose, and mouth

Please see the full Prescribing Information for Voltaren Gel available at www.VoltarenGel.com

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.

About OA

OA is the most common type of arthritis and often occurs in the hands and knees, with pain as a common symptom.  The condition occurs when cartilage and its underlying bone begin to deteriorate.   A direct cause of OA has not been determined, but risk factors such as aging, joint injury or stress, heredity, and being overweight can lead to the disease.

About the "Apply Yourself!" campaign

The "Apply Yourself!" Campaign, a partnership between Allan Houston and Endo Pharmaceuticals, aims to raise awareness of OA hand and knee pain and encourages sufferers to make pain relief a top priority by
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
2. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
3. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
4. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
5. Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
6. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
7. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
8. Former Miss USA Shawnae Jebbia Shines with Siemens Pure
9. Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
10. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
11. SCAI Statement on the Hospitalization of Former President Bill Clinton
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014  In an unprecedented effort to curb the ... in ambulances and other transport vehicles, an advanced and portable ... by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West ... the nation to begin sanitizing the interior surfaces of its ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, ... medical device company developing its Symphony® CGM System ... today announced that Robert F. Doman , ... will present at "TEN", Noble Financial Capital Markets, ... Doman will make a corporate presentation to prospective ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ... delivery systems especially for type 1 diabetes ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... -Knowledge May Improve Diagnosis for Children with Cornelia ... of scientists studying a rare genetic disease discovered ... function of keeping chromosomes together also plays an ... gene regulation is disrupted in the multisystem genetic ...
... Molecule Stem Cell Modulator Administered in Dual Cord Blood Transplant ... Fate Therapeutics, Inc. announced today that the first ... of FT1050, a small molecule Stem Cell Modulator (SCM) designed ... its activation of key pathways that guide cell fate. ...
Cached Medicine Technology:In Rare Disorder, a Familiar Protein Disrupts Gene Function 2In Rare Disorder, a Familiar Protein Disrupts Gene Function 3In Rare Disorder, a Familiar Protein Disrupts Gene Function 4Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 2Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 3Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 4
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... California youth have,teamed up with doctors, teachers, law ... announcing its intent to stop selling,Rockstar 21, the ... Alcopops and Youth is calling on Anheuser Busch, ... to follow,Rockstar,s lead. Sold in brightly colored ...
... approach of winter season brings with it an increase ... the United States, fires and burns result in almost ... all age groups. , A new study conducted by ... at Nationwide Childrens Hospital, concludes that burn-associated injuries among ...
... Wis., Nov. 12 Shopko announced today the,appointment ... President and Chief,Merchandising Officer. Jones will be responsible ... of the regional mass retailer. Jones, career ... the,department store sector, mid-tier chain stores and big ...
... Pa., Nov. 12 ViroPharma Incorporated,(Nasdaq: VPHM ... Medicinal,Products (COMP) of the European Medicines Agency (EMEA) ... prevention of cytomegalovirus (CMV),disease in patients with impaired ... designed to promote the,development of drugs which may ...
... target immune system cells sent to kill them, study ... have uncovered a cache of molecular weapons that helps ... virulent. , Though more work must be done, the ... are so successful in causing infection and gives a ...
... FALLS, Idaho, Nov. 12 International,Isotopes Inc. (OTC ... quarter and nine months ending September 30, 2007. ... periods ended September,30, 2007, was $1,486,112 and $3,592,049 ... same periods in 2006. These numbers,represent an increase ...
Cached Medicine News:Health News:Youth and Community Groups Commend Rockstar for Taking 'The Buzz' out of its Energy Drinks 2Health News:Youth and Community Groups Commend Rockstar for Taking 'The Buzz' out of its Energy Drinks 3Health News:Burn injuries take devastating toll on nation's children 2Health News:ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM) 2Health News:ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM) 3Health News:ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM) 4Health News:Key to MRSA Virulence in Community Discovered 2Health News:Key to MRSA Virulence in Community Discovered 3Health News:International Isotopes Inc. Announces Third Quarter and Nine Months 2007 Financial Results 2Health News:International Isotopes Inc. Announces Third Quarter and Nine Months 2007 Financial Results 3Health News:International Isotopes Inc. Announces Third Quarter and Nine Months 2007 Financial Results 4
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
... The TC-PLUS Solution tricompartmental total knee prosthesis ... knee arthroplasty. State-of-the-art design and manufacturing technologies ... optimum biomechanical function as well as a ... tibial insert to keep wear to a ...
... Knee System is a long term, quality ... Available in both posterior stabilized and anatomically ... System provides the flexibility needed to address ... ease of identification keeps the user in ...
... a long term, quality solution based on ... posterior stabilized and anatomically correct cruciate retaining ... flexibility needed to address patients' needs. In ... keeps the user in mind and promotes ...
Medicine Products: